254 related articles for article (PubMed ID: 32463428)
41. Expression of WT1 protein and correlation with cellular proliferation in glial tumors.
Hashiba T; Izumoto S; Kagawa N; Suzuki T; Hashimoto N; Maruno M; Yoshimine T
Neurol Med Chir (Tokyo); 2007 Apr; 47(4):165-70; discussion 170. PubMed ID: 17457020
[TBL] [Abstract][Full Text] [Related]
42. Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation.
Ito A; Kagawa S; Sakamoto S; Kuwada K; Kajioka H; Yoshimoto M; Kikuchi S; Kuroda S; Yoshida R; Tazawa H; Fujiwara T
BMC Cancer; 2021 Jan; 21(1):102. PubMed ID: 33509150
[TBL] [Abstract][Full Text] [Related]
43. Extracellular Vesicles in Brain Tumor Progression.
D'Asti E; Chennakrishnaiah S; Lee TH; Rak J
Cell Mol Neurobiol; 2016 Apr; 36(3):383-407. PubMed ID: 26993504
[TBL] [Abstract][Full Text] [Related]
44. CD38 deficiency in the tumor microenvironment attenuates glioma progression and modulates features of tumor-associated microglia/macrophages.
Levy A; Blacher E; Vaknine H; Lund FE; Stein R; Mayo L
Neuro Oncol; 2012 Aug; 14(8):1037-49. PubMed ID: 22700727
[TBL] [Abstract][Full Text] [Related]
45. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
[TBL] [Abstract][Full Text] [Related]
46. Suppression of SIRT6 by miR-33a facilitates tumor growth of glioma through apoptosis and oxidative stress resistance.
Chang M; Qiao L; Li B; Wang J; Zhang G; Shi W; Liu Z; Gu N; Di Z; Wang X; Tian Y
Oncol Rep; 2017 Aug; 38(2):1251-1258. PubMed ID: 28677777
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.
Wang H; Jiang D; Li W; Xiang X; Zhao J; Yu B; Wang C; He Z; Zhu L; Yang Y
Theranostics; 2019; 9(18):5347-5358. PubMed ID: 31410219
[No Abstract] [Full Text] [Related]
48. RBM17 controls apoptosis and proliferation to promote Glioma progression.
Lu J; Li Q; Cai L; Zhu Z; Guan J; Wang C; Xia J; Xia L; Wen M; Zheng W; Su Z; Wang C
Biochem Biophys Res Commun; 2018 Oct; 505(1):20-28. PubMed ID: 30227940
[TBL] [Abstract][Full Text] [Related]
49. Hypoxic Glioma Stem Cell-Derived Exosomes Containing Linc01060 Promote Progression of Glioma by Regulating the MZF1/c-Myc/HIF1α Axis.
Li J; Liao T; Liu H; Yuan H; Ouyang T; Wang J; Chai S; Li J; Chen J; Li X; Zhao H; Xiong N
Cancer Res; 2021 Jan; 81(1):114-128. PubMed ID: 33158815
[TBL] [Abstract][Full Text] [Related]
50. Gliomas Interact with Non-glioma Brain Cells via Extracellular Vesicles.
Gao X; Zhang Z; Mashimo T; Shen B; Nyagilo J; Wang H; Wang Y; Liu Z; Mulgaonkar A; Hu XL; Piccirillo SGM; Eskiocak U; Davé DP; Qin S; Yang Y; Sun X; Fu YX; Zong H; Sun W; Bachoo RM; Ge WP
Cell Rep; 2020 Feb; 30(8):2489-2500.e5. PubMed ID: 32101730
[TBL] [Abstract][Full Text] [Related]
51. Characterization of Arginase Expression in Glioma-Associated Microglia and Macrophages.
Zhang I; Alizadeh D; Liang J; Zhang L; Gao H; Song Y; Ren H; Ouyang M; Wu X; D'Apuzzo M; Badie B
PLoS One; 2016; 11(12):e0165118. PubMed ID: 27936099
[TBL] [Abstract][Full Text] [Related]
52. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.
Huang RQ; Wang SQ; Zhu QB; Guo SC; Shi DL; Chen F; Fang YC; Chen R; Lu YC
Mol Carcinog; 2019 Jan; 58(1):135-143. PubMed ID: 30255656
[TBL] [Abstract][Full Text] [Related]
53. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway.
Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y
FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796
[TBL] [Abstract][Full Text] [Related]
54. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
Roesch S; Rapp C; Dettling S; Herold-Mende C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
[TBL] [Abstract][Full Text] [Related]
55. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma.
Saw PE; Xu X; Kang BR; Lee J; Lee YS; Kim C; Kim H; Kang SH; Na YJ; Moon HJ; Kim JH; Park YK; Yoon W; Kim JH; Kwon TH; Choi C; Jon S; Chong K
Theranostics; 2021; 11(2):941-957. PubMed ID: 33391514
[TBL] [Abstract][Full Text] [Related]
56. Extracellular vesicles as biomarkers and therapeutic targets for cancer.
Urabe F; Kosaka N; Ito K; Kimura T; Egawa S; Ochiya T
Am J Physiol Cell Physiol; 2020 Jan; 318(1):C29-C39. PubMed ID: 31693397
[TBL] [Abstract][Full Text] [Related]
57. The emergent role of exosomes in glioma.
Gourlay J; Morokoff AP; Luwor RB; Zhu HJ; Kaye AH; Stylli SS
J Clin Neurosci; 2017 Jan; 35():13-23. PubMed ID: 27771233
[TBL] [Abstract][Full Text] [Related]
58. Extracellular Vesicle lncRNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 Released From Glioma Stem Cells Modulates the Inflammatory Response of Microglia After Lipopolysaccharide Stimulation Through Regulating miR-129-5p/High Mobility Group Box-1 Protein Axis.
Yang J; Sun G; Hu Y; Yang J; Shi Y; Liu H; Li C; Wang Y; Lv Z; Niu J; Liu H; Shi X; Wang H; Li P; Jiao B
Front Immunol; 2019; 10():3161. PubMed ID: 32117213
[TBL] [Abstract][Full Text] [Related]
59. Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility.
Zhu Z; Liu Y; Li K; Liu J; Wang H; Sun B; Xiong Z; Jiang H; Zheng J; Hu Z
Carcinogenesis; 2014 Aug; 35(8):1901-10. PubMed ID: 24876153
[TBL] [Abstract][Full Text] [Related]
60. Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy.
Yokota C; Kagawa N; Takano K; Chiba Y; Kinoshita M; Kijima N; Oji Y; Oka Y; Sugiyama H; Tsuboi A; Izumoto S; Kishima H; Hashimoto N
Cancer Immunol Immunother; 2022 Jan; 71(1):189-201. PubMed ID: 34089373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]